Once-promising anti-inflammatory drug fails to improve long-COVID functional outcomes in trial

A randomized clinical trial finds that the anti-inflammatory drug colchicine, once thought promising for treating COVID-19, is no better than placebo in terms of functional capacity, respiratory function, symptoms such as…